Pancreaticogastrostomy and prophylactic octreotide therapy in patients undergoing pancreaticoduodenectomy
New Egyptian Journal of Medicine [The]. 1999; 20 (Supp. 1): 45-52
em Inglês
| IMEMR
| ID: emr-51978
ABSTRACT
A series of 24 patients [16 males and 9 females] who underwent pancreaticoduodenectomy between February 1997 and November 1998 was included in this study. Pancreaticogastrostomy was used to reconstruct the pancreatic stump. Prophylactic octreotide therapy was used for a minimum of one week postoperatively. One patient died from postoperative bleeding and coagulopathy. Two patients developed pancreatic fistula which was resolved on a continuation of octreotide therapy and parentral nutrition within 14 days. There was no mortality or major morbidity related to the pancreatic fistula. It was concluded that pancreaticogastrostomy is a safe drainage procedure for the pancreatic stump after pancreaticoduodenectomy. The additional prophylactic use of octreotide could help in decreasing postoperative pancreatic fistula rate and its consequences
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Complicações Pós-Operatórias
/
Período Pós-Operatório
/
Gastrostomia
/
Octreotida
/
Fístula Pancreática
/
Sepse
/
Hemorragia
/
Infecções
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
New Egypt. J. Med.
Ano de publicação:
1999
Similares
MEDLINE
...
LILACS
LIS